VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $202,669 | -6.7% | 30,754 | -3.8% | 0.00% | -33.3% |
| Q1 2023 | $217,137 | -59.0% | 31,979 | -55.4% | 0.00% | 0.0% |
| Q4 2022 | $529,774 | +16.7% | 71,688 | +56.0% | 0.00% | -50.0% |
| Q3 2022 | $454,000 | -10.5% | 45,964 | -1.2% | 0.01% | -14.3% |
| Q2 2022 | $507,000 | -11.7% | 46,545 | -8.2% | 0.01% | +16.7% |
| Q1 2022 | $574,000 | -26.1% | 50,710 | +2.4% | 0.01% | -25.0% |
| Q4 2021 | $777,000 | – | 49,530 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
| Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
| Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
| Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
| EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
| Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
| EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
| ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
| 361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |